
Herbalife (HLF) Stock Forecast & Price Target
Herbalife (HLF) Analyst Ratings
Bulls say
Herbalife Ltd has demonstrated robust financial performance, with an EBITDA of $167 million for the fourth quarter, exceeding consensus estimates by $26 million, and the company raised its 2024 EBITDA guidance by $25 million at the mid-point. Additionally, the company has reported a positive trend in distributor growth, achieving a year-over-year increase of 22% for the third consecutive quarter, signaling a strengthening direct-selling business model. The improved EBITDA margin of 13.4% reflects a combination of positive pricing strategies and lower input costs, suggesting strong operational efficiency and resilience in the face of economic challenges.
Bears say
Herbalife Ltd reported a sales decline in 3Q24, with constant currency sales of -0.3% falling short of estimates due to weaknesses in vital markets such as China and North America. The company has revised its 2024 sales guidance downward, anticipating a mid-point of -1.5%, alongside a decline in volume points of -5.4%, indicating worsening sales performance. Additionally, risks associated with distributor relations, regulatory compliance, and consumer demand, especially for significant products like the Formula 1 Nutritional Shake Mix, pose substantial threats to the company's financial stability.
This aggregate rating is based on analysts' research of Herbalife and is not a guaranteed prediction by Public.com or investment advice.
Herbalife (HLF) Analyst Forecast & Price Prediction
Start investing in Herbalife (HLF)
Order type
Buy in
Order amount
Est. shares
0 shares